The result is targeted mobilization of the most dangerous fat compartment
In subkutanen Forschungsprotokollen werden typischerweise Dosen von 1 bis 4 mg pro Anwendung eingesetzt, mit einer Frequenz von 2 bis 3 Mal pro Woche
Yang L, Jiang L, Sun X, Li J, Wang N, Liu X, et al
Aids in the function of certain enzymes
Research Maturity and Clinical Data Sermorelin has a more extensive research history than Ipamorelin in published clinical literature, including trials demonstrating increased GH and IGF-1 levels in adults, research examining body composition parameters, studies examining effects on sleep architecture, and long-term safety data from its period of FDA approval for pediatric GH deficiency